Keratoconus: Your Most Common Questions Answered
Understanding the Basics of Keratoconus
Knowing what keratoconus is and how it behaves helps you take an active role in managing it. The more you understand the condition, the easier it is to recognize changes and ask the right questions at your appointments.
Keratoconus is more common than many people realize. It is estimated to affect roughly 289 out of every 100,000 people worldwide. Improved screening tools and wider access to corneal topography, a detailed map of the cornea's surface shape, have led to higher detection rates in recent years, meaning more people are being diagnosed than in previous decades.
Your eye care provider sees patients with this condition regularly, and treatment options have expanded significantly over the past decade.
Onset most often occurs during the teenage years through the mid-20s. The condition tends to progress during this window and typically stabilizes by the mid-30s to 40s, though the timeline varies from person to person.
If you are diagnosed in your teens, your cornea may still be actively changing. Your eye care provider will monitor your topography maps closely during this period to determine whether treatment is needed to stop further progression.
In the vast majority of cases, keratoconus affects both eyes, though one eye is usually more advanced than the other. You may notice symptoms primarily in one eye, but the second eye often has early changes that have not yet caused noticeable problems.
Regular topography screening of both eyes is important even when one eye feels fine. Changes in the second eye can develop years after the first eye was diagnosed, and catching them early expands your treatment options.
Treatment Options for Keratoconus
Treatment for keratoconus focuses on two goals: stopping the cornea from changing further and correcting the vision that has already been affected. The right approach depends on how advanced your condition is and how quickly it is progressing.
Corneal collagen cross-linking, often called CXL, is the only treatment proven to stop keratoconus progression. During the procedure, riboflavin (vitamin B2) drops are applied to the cornea and activated with ultraviolet light. This process strengthens the bonds between the collagen fibers inside the cornea, making it more resistant to further thinning and bulging.
The FDA approved the original epithelium-off CXL technique in 2016, which involves temporarily removing the outer corneal layer before treatment. In 2025, the FDA also approved an epithelium-on approach, which keeps the outer layer intact throughout the procedure. Your provider can explain which technique may be appropriate for your situation.
The majority of keratoconus patients, roughly 80 to 90 percent, manage their vision successfully with specialty contact lenses and never require a corneal transplant. Transplantation is reserved for cases where contact lenses can no longer provide usable vision or where corneal scarring is blocking the visual pathway.
Early treatment with CXL significantly reduces the risk of reaching the advanced stages where transplant becomes necessary. The sooner progression is stopped, the more corneal tissue and visual function can be preserved.
Specialty contact lenses are the primary way keratoconus patients correct their vision on a daily basis. Because the irregular corneal shape prevents standard soft lenses from providing clear sight, several specialized options have been developed.
- Rigid gas permeable (RGP) lenses sit directly on the cornea and create a smooth optical surface over the irregular shape
- Scleral lenses rest on the white part of the eye and vault completely over the cornea, making them very comfortable for many patients
- Hybrid lenses combine a rigid center with a soft outer skirt for patients who want the clarity of RGP lenses with more comfort
- Piggyback systems layer a soft lens beneath an RGP lens to improve comfort for sensitive corneas
Scleral lenses are associated with higher comfort and satisfaction for many keratoconus patients. Your contact lens specialist will select the best fit based on your corneal measurements and lifestyle.
Keratoconus and Everyday Life
Living with keratoconus raises practical questions about daily activities, family planning, and what to watch for over time. Understanding how the condition intersects with your daily life helps you protect your vision and plan ahead.
Most keratoconus patients maintain legal driving vision with properly fitted specialty contact lenses. With good correction in place, driving and other daily activities remain manageable for the majority of patients.
Night driving may be more challenging due to glare and halos around lights, which are common symptoms of an irregularly shaped cornea. Discuss your driving vision with your provider, and consider limiting nighttime driving if these symptoms make it feel unsafe.
Screen use does not cause or worsen keratoconus. The condition is driven by structural changes inside the cornea, not by how much time you spend reading or looking at screens.
That said, extended screen time can increase dry eye symptoms and eye fatigue, which may make your existing visual distortion feel more noticeable temporarily. The 20-20-20 rule (every 20 minutes, look at something 20 feet away for 20 seconds) and keeping artificial tears nearby can help manage screen-related discomfort without affecting your disease course.
Keratoconus has a genetic component, meaning first-degree relatives of someone with the condition have a higher chance of developing it. Corneal topography screening is recommended for children of affected parents, generally starting around ages 10 to 12.
If your child frequently rubs their eyes, has allergies, or has a frequently changing glasses prescription, mention your keratoconus history to their eye care provider. Eye rubbing is a known risk factor that can accelerate corneal changes in susceptible individuals, and early screening catches subclinical signs before symptoms appear.
Hormonal changes during pregnancy can temporarily affect corneal shape and contact lens fit. Some patients need lens adjustments during pregnancy as their prescription shifts.
CXL is typically deferred until after delivery. If you are pregnant or planning to become pregnant, let your provider know so your care plan can be adjusted accordingly.
Monitoring and Long-Term Outlook
Keratoconus is a lifelong condition, but with the right monitoring schedule and treatment plan, most patients maintain functional vision for decades. Understanding what to expect over time helps you stay consistent with your care.
For patients with active progression, corneal topography monitoring every three to six months is standard. This allows your provider to detect any changes quickly and act before vision deteriorates further.
Patients who have demonstrated stability after cross-linking or natural stabilization may transition to annual visits. Your specific schedule depends on your age, how quickly your cornea has been changing, and whether you have received CXL. Younger patients and those without cross-linking generally need more frequent follow-up.
Keratoconus progression often slows and stabilizes in the mid-30s to 40s, but this is not guaranteed for every patient. Waiting for natural stabilization carries the risk of unnecessary vision loss that cross-linking could have prevented during the progressive phase.
Even after stabilization, the corneal changes that occurred during progression are permanent. Specialty contact lenses or surgical options address the vision loss that accumulated before the condition stopped advancing.
Recurrence of ectasia, the thinning and bulging process, in donor corneal tissue after transplant is extremely rare. However, irregular astigmatism (uneven curvature of the cornea) often persists after the procedure, so specialty contact lenses or glasses are usually still needed for the best possible vision.
Transplant patients continue regular eye exams after surgery to monitor graft health and detect early signs of rejection. Proper follow-up care helps keep a healthy graft functioning well for many years.
Frequently Asked Questions
These are additional questions that come up often in our practice, covering situations that may not fit neatly into the topics above.
Flying is safe for keratoconus patients. The main consideration is comfort, since cabin air tends to be dry and can cause contact lens irritation on longer flights. Bringing preservative-free artificial tears and considering removing your lenses during overnight flights can make the experience more comfortable without any impact on your corneal health.
Currently, no treatment reverses keratoconus or restores the cornea to its original shape. Cross-linking halts progression, and specialty lenses or surgical options restore functional vision, but the structural changes that have already occurred remain. Research into new approaches continues, and staying connected with your care team ensures you have access to evolving options as they become available.
Skipping monitoring visits means your provider cannot detect whether your condition is progressing. If keratoconus worsens without being caught, you lose time during which cross-linking could have stopped the change and preserved more of your cornea. This is especially important during your teens and twenties, when progression tends to be most active and the window for intervention matters most.
Keratoconus almost always affects both eyes over time, even when only one has received a formal diagnosis. The second eye may have early, subclinical changes that are not yet causing symptoms but are visible on topography. This is why your provider examines both eyes at every visit, not just the one that brought you in initially.
Clinical trials for new keratoconus treatments are conducted at academic medical centers and specialized practices. Ask your provider whether any trials may be appropriate for your situation, or explore options through publicly available trial registries. Participation can sometimes provide access to emerging treatments and may offset certain costs, though eligibility varies by study.
See Our Team at ReFocus Eye Health Cheshire
Our team at ReFocus Eye Health Cheshire is experienced in diagnosing, treating, and monitoring keratoconus at every stage of the condition. We offer comprehensive corneal evaluations, specialty contact lens fittings, and access to the full range of treatment options available today. Whether you are newly diagnosed or have been managing keratoconus for years, we are here to help you protect your vision and make informed decisions about your care. We welcome patients from Southington, Wallingford, Naugatuck, and all surrounding areas.
I was very thrilled with this office and visit. Everyone is very nice and makes you feel right at home.
meredith minnocci
The office in Cheshire is run very efficiently and needless to say Dr. Masi is the best!!
richard beardsley
The staff were very friendly and helpful. Everyone was also very knowledgeable about any of my questions. Lastly, they were right on time and the appointment was efficient. Great experience.
Christine Milani
Staff is pleasant and extremely helpful. Dr. Oropesa is a true professional and I could not be happier with the care I received.
Kathy Stephens
A smooth visit from check-in to check-out. The staff was very pleasant and Dr Swan is a phenomenal physician. One of Connecticut’s best!
Gerorge Merriam
Contact Us
Tuesday: Array
Wednesday: Array
Thursday: Array
Friday: Array
Saturday: Array
Sunday: Array